TopFunds

Cencora

NYSE: COR

Stock price

334.27 USD

(+0%) TODAY

Health Care DistributorsMedical - Distribution
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
(0.6)
6.3
1.6
7.5
4
(16.6)
7.4
8
8.5
7.5
8
-
02Free cash flow per share
16.9
12
4.6
4.9
9.6
9
10.7
10.4
16.9
15
16.4
(0.3)%
03Dividends per share
1.6
1.4
2.4
2.6
2.8
1.7
3
3.1
1.9
2
2.2
3.4%
04Dividends payout, %
(1.9)%
20.2%
77.3%
20.1%
39.6%
(10.1)%
23.8%
23.1%
22.9%
27.6%
28.1%
-
PROFIT AND LOSS STATEMENT
05Revenue
$ 135,962
$ 146,850
$ 153,144
$ 167,940
$ 179,589
$ 189,894
$ 213,989
$ 238,587
$ 262,173
$ 293,959
$ 321,333
9%
06% Change
-
8%
4.3%
9.7%
6.9%
5.7%
12.7%
11.5%
9.9%
12.1%
9.3%
9%
07Cost of revenue
(132,747)
(143,076)
(148,997)
(163,828)
(175,059)
(185,102)
(207,720)
(230,986)
(254,417)
(285,257)
(311,191)
8.9%
08Gross profit
3,215
3,774
4,147
4,111
4,530
4,792
6,269
7,601
7,757
8,701
10,142
12.2%
09% Margin
2.4%
2.6%
2.7%
2.5%
2.5%
2.5%
2.9%
3.2%
3%
3%
3.2%
2.8% A
10Operating expenses
(1,908)
(2,091)
(2,129)
(2,460)
(2,664)
(2,767)
(3,594)
(4,849)
(5,310)
(5,661)
(6,494)
13%
11% of Revenue
(1.4)%
(1.4)%
(1.4)%
(1.5)%
(1.5)%
(1.5)%
(1.7)%
(2)%
(2)%
(1.9)%
(2)%
(1.7)% A
12Operating Income
1,307
1,683
2,018
1,651
1,867
2,025
2,675
2,752
2,447
3,040
3,648
10.8%
13Income tax expense
(409)
(37)
(553.4)
(438.5)
(113)
(1,894)
(677.3)
(516.5)
(428.3)
(484.7)
(690.5)
5.4%
14Net Income
(134.9)
1,428
414.5
1,658
855.4
(3,400)
1,540
1,699
1,745
1,509
1,554
-
15% Margin
(0.1)%
1%
0.3%
1%
0.5%
(1.8)%
0.7%
0.7%
0.7%
0.5%
0.5%
0.4% A
16Shares Outstanding
217,786
225,959
221,602
220,336
211,840
204,783
208,465
211,210
204,591
200,284
195,214
(1.1)%
17EPS Basic
(0.6)
6.7
1.7
7.6
4.1
(16.6)
7.5
8.2
8.6
7.6
8
-
18EPS Diluted
(0.6)
6.3
1.6
7.5
4
(16.6)
7.4
8
8.5
7.5
8
-
19EBITDA
630.6
1,920
1,490
1,867
1,651
(4,734)
2,919
3,125
3,417
3,372
3,747
19.5%
% Margin
0.5%
1.3%
1%
1.1%
0.9%
(2.5)%
1.4%
1.3%
1.3%
1.2%
1.2%
0.8% A
20Net Interest Income (expense)
(109)
(139.9)
(145.2)
(174.7)
(157.8)
(137.9)
(174.1)
(210.7)
(228.9)
(157)
(291.5)
10.3%
21Net Debt / EBITDA
2.5
0.9
0.9
1.2
0.7
(0.1)
2.1
1.3
1.2
1
1.7
1.2 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
2,167
2,742
2,435
2,493
3,374
4,598
2,547
3,533
2,690
3,231
4,395
7.3%
23Short-term investments
50.8
26.1
-
-
-
-
-
-
-
-
-
-
24Accounts receivable
8,223
9,176
10,303
11,314
12,387
14,299
18,389
18,625
20,911
23,872
25,225
11.9%
25Other current assets
189
148.3
118.6
169.1
1,311
1,534
2,498
342.9
1,841
1,715
2,127
27.4%
26Inventory
9,755
10,724
11,461
11,919
11,060
12,589
15,368
17,089
17,455
18,999
20,493
7.7%
27Total Current Assets
20,335
22,790
24,303
25,894
28,132
33,020
38,803
39,590
42,799
47,718
52,239
9.9%
Non-Current Assets
28Net property, plant & equipment
1,193
1,531
1,798
1,892
1,771
1,928
3,230
3,080
3,155
3,323
4,088
13.1%
29Long-term investments
30.5
56.7
57.6
-
(1,860)
-
-
60.4
63.1
66.6
-
-
30Other non-current assets
6,179
9,212
9,158
9,883
11,130
9,291
15,305
13,831
16,542
15,994
20,264
12.6%
31Total Non-Current Assets
7,402
10,800
11,013
11,776
11,040
11,219
18,535
16,971
19,760
19,384
24,351
12.7%
Total Assets
27,736
33,590
35,317
37,670
39,172
44,275
57,338
56,561
62,559
67,102
76,590
10.7%
LIABILITIES
Current Liabilities
32Accounts payable
20,886
23,926
25,404
26,837
28,385
31,705
38,010
40,193
45,836
50,942
54,720
10.1%
33Short-term debt
-
610.2
12.1
151.7
139
593.8
475.6
1,229
823.8
781.1
371.6
-
34Other current liabilities
1,814
699.7
1,352
881.2
1,057
1,554
2,873
2,056
2,171
2,554
2,729
4.2%
35Total Current Liabilities
22,701
25,236
26,768
27,870
29,581
33,853
41,359
43,478
48,831
54,277
57,821
9.8%
Non-Current Liabilities
36Long-term debt
3,493
3,853
3,782
4,159
4,034
4,389
8,276
6,361
5,995
5,872
10,376
11.5%
37Other non-current liabilities
2,275
2,375
2,652
2,940
2,851
6,872
7,119
6,651
7,067
6,166
6,646
11.3%
38Total Non-Current Liabilities
5,768
6,228
6,434
7,099
6,885
11,261
15,395
13,011
13,061
12,038
17,023
11.4%
39Total Liabilities
27,347
31,508
33,252
34,968
36,466
45,115
56,753
56,489
61,893
66,315
74,843
10.6%
SHAREHOLDERS` EQUITY
40Common stock
2.8
2.8
2.8
2.8
2.9
2.9
2.9
2.9
2.9
3
3
0.8%
41Retained earnings / (deficit)
1,182
2,304
2,395
3,721
4,236
518.3
1,671
2,978
4,324
5,417
6,534
18.7%
42Accumulated other comprehensive income / (loss)
(136.3)
(114.3)
(95.8)
(79.3)
(112)
(108.8)
(445.4)
(1,831)
(1,403)
(989.1)
(901.4)
20.8%
43Noncontrolling interests
-
-
-
117.1
114.3
179.3
361.1
282.8
144.3
140.8
239.1
-
44Total shareholders' equity
633.5
2,129
2,115
3,050
2,993
(839.6)
584.4
71.3
666.3
786.7
1,747
10.7%
45Total Liabilities and shareholders' Equity
27,736
33,590
35,317
37,670
39,172
44,275
57,338
56,561
62,559
67,102
76,590
10.7%
46Total Debt
3,739
4,463
3,794
4,663
4,493
4,983
8,752
7,590
6,818
6,653
10,748
11.1%
47Net Debt
1,572
1,721
1,359
2,170
1,119
385.4
6,204
4,056
4,129
3,422
6,353
15%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
(134.9)
1,428
414.5
1,658
855.4
(3,400)
1,540
1,699
1,745
1,509
1,554
-
49Depreciation & amortization
249.6
385
422.9
499.6
488.5
401.6
514.8
709.8
980.8
1,119
1,068
15.7%
50Share-based compensation expense
60.9
65
62.2
62.3
58.9
74.4
99.6
93.4
124.6
148
148
9.3%
51Changes in working capital and other assets
3,745
1,301
589.4
(809)
941.2
5,131
512.3
201
1,061
708.7
1,105
(11.5)%
52Net cash flows from operating activities
3,920
3,179
1,489
1,411
2,344
2,207
2,667
2,703
3,911
3,485
3,875
(0.1)%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(231.6)
(464.6)
(466.4)
(336.4)
(310.2)
(369.7)
(438.2)
(496.3)
(458.4)
(487.2)
(668)
11.2%
54Purchases of investments / marketable securities
(86.2)
(19)
(48.6)
-
13.7
(56.1)
-
-
-
-
-
-
55Proceeds from maturities of marketable securities
231.6
59.7
26.1
-
(13.7)
369.7
-
-
-
-
-
-
56Other investing activities
(2,845)
(2,745)
(9.2)
(774.7)
(65.6)
(323.8)
(5,703)
127.9
(2,144)
(130.9)
(4,309)
4.2%
57Net cash flows from investing activities
(2,931)
(3,169)
(498)
(1,111)
(375.8)
(379.9)
(6,142)
(368.4)
(2,603)
(618.1)
(4,977)
5.4%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(1,845)
168.9
(227)
(500.8)
(597.8)
(194.6)
116.6
(389.8)
(1,120)
(1,454)
(406.3)
(14)%
59Dividends paid, net
(253.9)
(288.5)
(320.3)
(333)
(339)
(343.6)
(366.6)
(391.7)
(398.8)
(416.2)
(437.1)
5.6%
60Debt issuance (repayments), net
1,496
713.2
(749.6)
635.7
(133.1)
(32)
2,217
(923.1)
(623.3)
(385.5)
3,196
7.9%
61Other financing activities
(27.6)
(28.6)
(16)
(44.7)
(16.7)
(33.5)
(13.7)
(48.2)
(80.7)
(75.8)
(103.1)
14.1%
62Net cash flows from financing activities
(630.3)
565.1
(1,313)
(242.9)
(1,087)
(603.6)
1,953
(1,753)
(2,222)
(2,331)
2,249
-
63Increase (decrease) in cash and cash equivalents
358.9
574.4
(321.8)
57.4
881.7
1,224
(1,528)
523.4
(840.6)
545
1,097
11.8%
64Cash and equivalents, ending balance
2,167
2,742
2,420
2,493
3,374
4,598
3,070
3,594
2,753
3,298
4,395
7.3%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
3,689
2,714
1,023
1,075
2,034
1,837
2,228
2,207
3,453
2,998
3,207
(1.4)%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

Cencora (COR) financial statements and performance

Explore Cencora (COR) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.